Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

Br J Haematol. 2000 Oct;111(1):18-29. doi: 10.1046/j.1365-2141.2000.02196.x.

Authors

R Champlin¹, I Khouri, A Shimoni, J Gajewski, S Kornblau, J Molldrem, N Ueno, S Giralt, P Anderlini

Affiliation

¹ Department of Blood and Marrow Transplantation, University of Texas-MD Anderson Cancer Center, Houston 77030, USA. rchampli@mdacc.tmc.edu

PMID: 11091179
DOI: 10.1046/j.1365-2141.2000.02196.x

No abstract available

Publication types

Review

MeSH terms

Bone Marrow Transplantation / methods*
Graft vs Host Disease
Graft vs Leukemia Effect
Graft vs Tumor Effect*
Humans
Immunotherapy, Adoptive / methods*
Lymphoma / therapy*
T-Lymphocytes / transplantation
Transplantation, Homologous